Abstract
- -
COVID-19 infection is associated with hypercoagulability and a prothrombotic state.
- -
Little is understood about the prevalence of venous thromboembolism in mild disease.
- -
We present a case of mild COVID-19 complicated by extensive deep venous thrombosis.
MeSH terms
-
Anticoagulants / therapeutic use
-
Antiviral Agents / therapeutic use
-
Betacoronavirus / drug effects
-
Betacoronavirus / pathogenicity*
-
COVID-19
-
COVID-19 Drug Treatment
-
Coronavirus Infections / blood
-
Coronavirus Infections / diagnosis
-
Coronavirus Infections / drug therapy
-
Coronavirus Infections / virology*
-
Host-Pathogen Interactions
-
Humans
-
Male
-
Middle Aged
-
Pandemics
-
Pneumonia, Viral / blood
-
Pneumonia, Viral / diagnosis
-
Pneumonia, Viral / drug therapy
-
Pneumonia, Viral / virology*
-
SARS-CoV-2
-
Treatment Outcome
-
Venous Thrombosis / blood
-
Venous Thrombosis / diagnostic imaging
-
Venous Thrombosis / therapy
-
Venous Thrombosis / virology*
Substances
-
Anticoagulants
-
Antiviral Agents